Literature DB >> 18486039

Clarithromycin.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18486039     DOI： 10.1016/S1472-9792(08)70005-2

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN： 1472-9792            Impact factor:   3.131


× No keyword cloud information.
  3 in total

1.  Synergistic drug combination effectively blocks Ebola virus infection.

Authors:  Wei Sun; Shihua He; Carles Martínez-Romero; Jennifer Kouznetsova; Gregory Tawa; Miao Xu; Paul Shinn; Ethan Fisher; Yan Long; Omid Motabar; Shu Yang; Philip E Sanderson; Peter R Williamson; Adolfo García-Sastre; Xiangguo Qiu; Wei Zheng
Journal:  Antiviral Res       Date:  2016-11-24       Impact factor: 5.970

2.  Clarithromycin Solid Lipid Nanoparticles for Topical Ocular Therapy: Optimization, Evaluation and In Vivo Studies.

Authors:  Anroop B Nair; Jigar Shah; Bandar E Al-Dhubiab; Shery Jacob; Snehal S Patel; Katharigatta N Venugopala; Mohamed A Morsy; Sumeet Gupta; Mahesh Attimarad; Nagaraja Sreeharsha; Pottathil Shinu
Journal:  Pharmaceutics       Date:  2021-04-09       Impact factor: 6.321

Review 3.  Looking beyond Typical Treatments for Atypical Mycobacteria.

Authors:  Clara M Bento; Maria Salomé Gomes; Tânia Silva
Journal:  Antibiotics (Basel)       Date:  2020-01-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.